Form 483

HeartSine Technologies Ltd Form 483, 2011-01-28

FDA issued a Form 483 to HeartSine Technologies Ltd on 2011-01-28 with 3 public-safe observations.

483· Form 483 issued3 observations

HeartSine Technologies Ltd · Belfast, United Kingdom · Issued January 28, 2011

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Jan 2011
21 CFR 820.30(g)

Design validation- Lack of or inadequate procedures

Cited by Christine M Parmentier

28 Jan 2011
21 CFR 820.70(a)

Process control procedures, Lack of or inadequate procedures

Cited by Christine M Parmentier

28 Jan 2011
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by Christine M Parmentier

Inspected site

HTHeartSine Technologies LtdBelfast, United Kingdom

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.198(a)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.70(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere